Screening: Babies
The question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 2 December 2025 to Question 93697, whether he has made an estimate of the differences in the number of conditions screened for in newborns between the UK and other countries such as Norway, Australia, Italy, Poland, and the Netherlands; and how those differences relate to the internationally recognised criteria used by the UK National Screening Committee.
Answered by Ashley Dalton
Screening programmes in the United Kingdom have a more rigorous approach towards evaluating the benefits and harms of screening compared to many other countries such as the United States of America and Italy.
The independent UK National Screening Committee (UK NSC), which is made up of leading medical and screening experts, advises Ministers in all four nations of the UK on the evidence on screening. Where the Committee is confident that screening provides more good than harm, they recommend a screening programme.
Some countries often cited as screening more conditions than the UK are not always running national programmes. Some countries or regions screen for a condition when it is only at the pilot or research stage. Some ‘screening programmes’ just test for a condition rather than being end-to-end quality-assured programmes that include diagnosis, treatment and care. And screening in some countries is delivered regionally, or even just by individual hospitals, rather than nationally. They are therefore not directly comparable to the national screening programmes offered in the UK.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →